Related Experiment Video
Updated: Feb 20, 2026

Videomorphometric Analysis of Hypoxic Pulmonary Vasoconstriction of Intra-pulmonary Arteries Using Murine Precision Cut Lung Slices
Published on: January 14, 2014
Hypoxia and Local Inflammation in Pulmonary Artery Structure and Function.
Michael Thompson1, Rodney D Britt1, Christina M Pabelick1,2
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, 4-184 W Jos SMH, 200 First St SW, Rochester, MN, 55905, USA.
Hypoxia contributes to pulmonary hypertension (PH) by altering pulmonary arteries (PA). This chapter explores thymic stromal lymphopoietin (TSLP) and brain-derived neurotrophic factor (BDNF) roles in hypoxia-driven PA changes relevant to PH.
Area of Science:
- Pulmonary vascular disease research
- Cardiovascular and respiratory science
Background:
- Hypoxia is a key factor in pulmonary hypertension (PH) development.
- Hypoxia-induced inflammation impacts pulmonary artery (PA) structure and function in PH.
- Thymic stromal lymphopoietin (TSLP) and brain-derived neurotrophic factor (BDNF) are implicated in nonvascular diseases.
Purpose of the Study:
- To investigate the potential roles of TSLP and BDNF in hypoxia-related PA remodeling.
- To explore TSLP and BDNF's influence on PA endothelial cells (PAECs) and PA smooth muscle cells (PASMCs).
- To understand TSLP and BDNF's effects on PA cellular functions relevant to PH.
Main Methods:
- Review of existing literature on TSLP, BDNF, hypoxia, and pulmonary hypertension.
- Focus on cellular mechanisms within PAECs and PASMCs.
- Analysis of TSLP and BDNF effects on intracellular calcium (Ca2+) responses and cell proliferation.
Main Results:
- TSLP and BDNF may exert noncanonical effects on PA cells, similar to their roles in airway diseases.
- These factors could influence PAECs and PASMCs, contributing to PA structural and functional changes.
- TSLP and BDNF may modulate intracellular Ca2+ signaling and cell proliferation in PA cells.
Conclusions:
- TSLP and BDNF are potential therapeutic targets for PH.
- Understanding their noncanonical roles in PA cells is crucial for developing novel PH treatments.
- Further research is needed to elucidate signaling pathways involved in TSLP and BDNF-mediated PA changes.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Peripheral Artery Disease I: Introduction
Inflammation
Coronary Artery Disease II: Pathophysiology

